Alzheimer's disease

News

Vounatsos heading for exit as Biogen sidelines Aduhelm

Biogen has announced a major revamp of its business that will see chief executive Michel Vounatsos depart the company, and all commercial activities related to troubled Alzheimer's therapy

News

Closeup of X-ray photography of human brain

Biogen pulls EU application for Alzheimer's drug Aduhelm

Biogen has given up on seeking approval for its Alzheimer's disease therapy Aduhelm in the EU, saying that discussions with EU regulators had made it clear the current data for the drug is

News

CMS decision on Aduhelm is in, and it's bad news for Biogen

The US Centres for Medicare and Medicaid Services (CMS) has firmed up its draft decision to limit reimbursement of Biogen's Alzheimer's disease therapy Aduhelm to a few thousand patients en

News

Study uncovers new Alzheimer's genes, links to immune disrup...

The largest-ever study of genetics in Alzheimer's disease patients has identified 42 new genes that appear to be linked to the neurodegenerative disorder.

News

Irish wearables firm Kinesis bought by Linus Health

University College Dublin spinout Kinesis Health Technologies, which has developed a range of wearable sensors to assess the physical capabilities of patients, has been bought by US company

News

Biogen finally publishes its phase 3 Aduhelm data

After months of debate about the validity of its phase 3 clinical trials for Alzheimer's therapy Aduhelm, Biogen has published the results in a peer-review journal, allowing physicians to l

Vounatsos heading for exit as Biogen sidelines Aduhelm

Biogen pulls EU application for Alzheimer's drug Aduhelm

CMS decision on Aduhelm is in, and it's bad news for Biogen

Study uncovers new Alzheimer's genes, links to immune disrup...

Irish wearables firm Kinesis bought by Linus Health

Biogen finally publishes its phase 3 Aduhelm data

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Alzheimer's disease

Editor's Picks